Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIANP | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
mRNA | LRRC37B | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | PAXIP1 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | CBX2 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | PIAS2 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | RNF138 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | ADAM22 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | CNOT9 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | SNRNP70 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | SEMA6C | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |